Literature DB >> 19443727

Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes.

Guomin Jiang1, Yan Ke, Deming Sun, Yali Wang, Henry J Kaplan, Hui Shao.   

Abstract

PURPOSE: To determine whether Toll-like receptor (TLR) ligands regulate the activation of retinal astrocytes (RACs) and the possible role of RACs in the polarization of interphotoreceptor retinoid-binding protein (IRBP)-specific T cells.
METHODS: TLR expression on RACs isolated from C57BL/6 mice was examined using real-time PCR and flow cytometry. The ability of RACs before or after treatment with TLR ligands to interact with T cells was assessed by measuring major histocompatibility complex class II and costimulatory molecule expression and cytokine production. The stimulatory effect of RACs, with or without TLR stimulation, on responder IRBP-specific T cells was examined by T-cell proliferation, cytokine production, and disease-inducing ability.
RESULTS: Cultured mouse RACs expressed TLR2, TLR3, and TLR4. Different TLR ligands had distinct stimulatory effects on RACs. PolyI:C (a TLR3 ligand) had the greatest effect in stimulating RACs to acquire antigen-presentation function, whereas BLP (a TLR2 ligand) had the lowest effect. TLR3 ligation increased the expression of MHC and costimulatory molecules and induced the production of IL-6, IL-12, and IL-23 by RACs. IRBP-specific T cells activated by polyI:C-treated RACs expanded vigorously, produced significant amounts of IFN-gamma and IL-17, and induced experimental autoimmune uveitis when injected into naive mice.
CONCLUSIONS: The stimulatory effect of RACs on autoreactive T cells is regulated by TLR ligands. TLR3 had a marked effect on the ability of RACs to promote the activation of Th1 and Th17 IRBP-specific T cells. Thus, exposure to microbial antigen(s) may alter susceptibility to autoimmune uveitis by promoting the activation of autoreactive T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443727      PMCID: PMC3271723          DOI: 10.1167/iovs.08-3303

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

Review 1.  Toll-like receptor control of the adaptive immune responses.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

Review 3.  Toll-like receptors, endogenous ligands, and systemic autoimmune disease.

Authors:  Ian R Rifkin; Elizabeth A Leadbetter; Liliana Busconi; Gregory Viglianti; Ann Marshak-Rothstein
Journal:  Immunol Rev       Date:  2005-04       Impact factor: 12.988

4.  ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.

Authors:  Saman Khayyamian; Andreas Hutloff; Kerstin Büchner; Michael Gräfe; Volker Henn; Richard A Kroczek; Hans W Mages
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

5.  The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACS.

Authors:  Stephan R Thurau; Thorsten R Mempel; Alexander Flügel; Maria Diedrichs-Möhring; Fritz Krombach; Naoto Kawakami; Gerhild Wildner
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

6.  Lymphotoxin beta receptor-Ig fusion protein treatment blocks actively induced, but not adoptively transferred, uveitis in Lewis rats.

Authors:  Hui Shao; Yangxin Fu; Lei Song; Sheher Sun; Herry J Kaplan; Deming Sun
Journal:  Eur J Immunol       Date:  2003-06       Impact factor: 5.532

Review 7.  Development of TLR inhibitors for the treatment of autoimmune diseases.

Authors:  Franck J Barrat; Robert L Coffman
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

8.  Commentary: adaptive immunity in the absence of innate immune responses? The un-Tolled truth of the silent invaders.

Authors:  Stefan Ehlers
Journal:  Eur J Immunol       Date:  2004-07       Impact factor: 5.532

9.  A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.

Authors:  Grégory Gautier; Martine Humbert; Florence Deauvieau; Mathieu Scuiller; John Hiscott; Elizabeth E M Bates; Giorgio Trinchieri; Christophe Caux; Pierre Garrone
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

10.  Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion.

Authors:  Naoto Kawakami; U Valentin Nägerl; Francesca Odoardi; Tobias Bonhoeffer; Hartmut Wekerle; Alexander Flügel
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

View more
  21 in total

1.  Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling.

Authors:  Cheng Luo; Xiangjun Yang; Angela D Kain; David W Powell; Markus H Kuehn; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

Review 2.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

3.  PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells.

Authors:  Yan Ke; Deming Sun; Guomin Jiang; Henry J Kaplan; Hui Shao
Journal:  J Leukoc Biol       Date:  2010-08-25       Impact factor: 4.962

Review 4.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

5.  Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.

Authors:  Andrew W Taylor; Henry J Kaplan
Journal:  Ocul Immunol Inflamm       Date:  2010-12       Impact factor: 3.070

6.  Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization.

Authors:  Amir Reza Hajrasouliha; Guomin Jiang; Qingxian Lu; Huayi Lu; Henry J Kaplan; Huang-Ge Zhang; Hui Shao
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

7.  Toll-like receptors 4, 5, 6 and 7 are constitutively expressed in non-human primate retinal neurons.

Authors:  Monica M Sauter; Aaron W Kolb; Curtis R Brandt
Journal:  J Neuroimmunol       Date:  2018-06-11       Impact factor: 3.478

Review 8.  Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis.

Authors:  Ashok Kumar; Rajeev K Pandey; Lindsay J Miller; Pawan K Singh; Mamta Kanwar
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

9.  The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis.

Authors:  Kevin M Brown; Ira J Blader
Journal:  J Ocul Biol Dis Infor       Date:  2009-12-12

10.  Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury.

Authors:  Galina Dvoriantchikova; David J Barakat; Eleut Hernandez; Valery I Shestopalov; Dmitry Ivanov
Journal:  Mol Vis       Date:  2010-09-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.